AU2749297A - Generation of viral transfectants using recombinant DNA-derived nucleoc apsid proteins - Google Patents

Generation of viral transfectants using recombinant DNA-derived nucleoc apsid proteins

Info

Publication number
AU2749297A
AU2749297A AU27492/97A AU2749297A AU2749297A AU 2749297 A AU2749297 A AU 2749297A AU 27492/97 A AU27492/97 A AU 27492/97A AU 2749297 A AU2749297 A AU 2749297A AU 2749297 A AU2749297 A AU 2749297A
Authority
AU
Australia
Prior art keywords
nucleoc
apsid
proteins
derived
generation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27492/97A
Inventor
Mark L. Hemphill
Michael W. Shaw
Xiyan Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2749297A publication Critical patent/AU2749297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16162—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU27492/97A 1996-05-01 1997-04-30 Generation of viral transfectants using recombinant DNA-derived nucleoc apsid proteins Abandoned AU2749297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1790796P 1996-05-01 1996-05-01
US60017907 1996-05-01
PCT/US1997/007277 WO1997041245A1 (en) 1996-05-01 1997-04-30 Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins

Publications (1)

Publication Number Publication Date
AU2749297A true AU2749297A (en) 1997-11-19

Family

ID=21785209

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27492/97A Abandoned AU2749297A (en) 1996-05-01 1997-04-30 Generation of viral transfectants using recombinant DNA-derived nucleoc apsid proteins

Country Status (5)

Country Link
EP (1) EP0906442A1 (en)
JP (1) JP2000509280A (en)
AU (1) AU2749297A (en)
CA (1) CA2253595A1 (en)
WO (1) WO1997041245A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0864645T3 (en) 1995-10-31 2005-10-24 Dnavec Research Inc Negative stranded RNA virus vector with autonomic replication activity
KR100525687B1 (en) 1995-11-01 2005-11-25 가부시끼가이샤 디나벡 겡뀨쇼 Recombinant Sendai Virus
CN108130345A (en) 2012-01-24 2018-06-08 乔治亚大学研究基金公司 Vaccine based on parainfluenza virus 5
WO2016148195A1 (en) * 2015-03-17 2016-09-22 一般財団法人阪大微生物病研究会 Cells for influenza virus production
CN104940233B (en) * 2015-06-29 2020-02-21 湖南科伦制药有限公司 Preparation method of anti-hepatitis B immune ribonucleic acid freeze-dried powder injection
CN110607281B (en) * 2019-09-11 2022-11-08 浙江鼎持生物制品有限公司 VERO cell strain with RAGB coding gene inserted therein and construction method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
WO1992016619A1 (en) * 1991-03-19 1992-10-01 Us Army Expression of influenza nucleoprotein antigens in baculovirus
ZA937164B (en) * 1992-09-28 1994-05-23 Commw Scient Ind Res Org Delivery system
AU3760495A (en) * 1994-09-30 1996-04-26 Aviron Chimeric Influenza Virus And Electroporation Method

Also Published As

Publication number Publication date
JP2000509280A (en) 2000-07-25
WO1997041245A1 (en) 1997-11-06
CA2253595A1 (en) 1997-11-06
EP0906442A1 (en) 1999-04-07

Similar Documents

Publication Publication Date Title
AU688210B2 (en) Recombinant obese (Ob) proteins
AU6198298A (en) Preparation of recombinant FVIII in a protein free medium
AU6255096A (en) Pegylated modified proteins
AU4803196A (en) Recombinant DNA virus and method for preparation thereof
AU3119895A (en) Recombinant virus vectors
AU3549397A (en) Over-expression of proteins
AU5320296A (en) Modified viral envelope polypeptide
AU2091799A (en) Uses of alpha-conotoxin peptides
AU6873596A (en) Allergen-xcd32 fusion proteins
AU4394396A (en) Modified peptides
AU3804397A (en) Hexameric fusion proteins and uses therefor
AU9798398A (en) Gfp-annexin fusion proteins
AUPO026596A0 (en) Viral peptide
AU1655297A (en) Anti-Fas recombinant antibodies and DNA therefor
AU1629197A (en) Expression of a foamy virus envelope protein
AU2749297A (en) Generation of viral transfectants using recombinant DNA-derived nucleoc apsid proteins
AU5652396A (en) Glucose-inducible recombinant viral vector
AU5021796A (en) Recombinant human anti-lewis b antibodies
ZA963530B (en) Recombinant obese (ob) proteins
AU6301698A (en) Anti-hiv peptides and proteins
AU4582597A (en) Therapeutic proteins
AU4798699A (en) Novel g protein-conjugated receptor protein and dna thereof
AU4661697A (en) Pfs28 fusion proteins
AU3443397A (en) Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation
AU1860397A (en) Ebna2 peptides and methods of using same

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted